OncLive | Genmab Focuses Oncology Research on Monoclonal Antibodies OncLive Tony Berberabe, MPH. Published Online: Thursday, February 6, 2014. Genmab, the publicly traded, international biotechnology company, has an oncology pipeline that focuses on two classes of drugs: naked antibodies and antibody drug conjugates (ADCs). |
